FDA — authorised 9 July 1980
- Application: NDA050537
- Marketing authorisation holder: PFIZER
- Local brand name: CLEOCIN
- Indication: SWAB — TOPICAL
- Status: approved
🇺🇸 Cefadroxil discontinued early in United States
FDA authorised Cefadroxil discontinued early on 9 July 1980
Marketing authorisations
FDA — authorised 6 August 1980
- Application: NDA050528
- Marketing authorisation holder: WARNER CHILCOTT
- Local brand name: DURICEF
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 12 September 1980
- Application: NDA050527
- Marketing authorisation holder: WARNER CHILCOTT
- Local brand name: DURICEF
- Indication: FOR SUSPENSION — ORAL
- Status: approved
FDA — authorised 7 April 1986
- Application: ANDA062644
- Marketing authorisation holder: PFIZER
- Local brand name: CLEOCIN
- Indication: FOR SOLUTION — ORAL
- Status: approved
FDA — authorised 11 August 1992
- Application: NDA050680
- Marketing authorisation holder: PFIZER
- Local brand name: CLEOCIN
- Indication: CREAM — VAGINAL
- Status: approved
FDA — authorised 13 August 1999
- Application: NDA050767
- Marketing authorisation holder: PFIZER
- Local brand name: CLEOCIN
- Indication: SUPPOSITORY — VAGINAL
- Status: approved
Other Infectious Disease approved in United States
Frequently asked questions
Is Cefadroxil discontinued early approved in United States?
Yes. FDA authorised it on 9 July 1980; FDA authorised it on 6 August 1980; FDA authorised it on 12 September 1980.
Who is the marketing authorisation holder for Cefadroxil discontinued early in United States?
PFIZER holds the US marketing authorisation.